Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics

Core Insights - Dentsply International reported $904 million in revenue for Q3 2025, a year-over-year decline of 4.9%, with an EPS of $0.37 compared to $0.50 a year ago, indicating a significant drop in earnings [1] - The revenue exceeded the Zacks Consensus Estimate of $901.59 million by 0.27%, while the EPS fell short of the consensus estimate of $0.45 by 17.78% [1] Revenue Breakdown - Revenue in the United States was $291 million, below the estimated $333.9 million, reflecting a year-over-year decline of 22.2% [4] - Revenue from the Rest of the World reached $231 million, slightly above the estimated $211.1 million, marking a year-over-year increase of 0.4% [4] - European revenue was $382 million, surpassing the average estimate of $360.92 million, with a year-over-year growth of 10.1% [4] Net Sales Performance - Connected Technology Solutions reported net sales of $259 million, slightly above the estimate of $253.17 million, but down 3.7% year over year [4] - Wellspect Healthcare achieved net sales of $83 million, exceeding the estimate of $76.63 million, with a year-over-year increase of 15.3% [4] - Essential Dental Solutions had net sales of $357 million, below the estimate of $367.93 million, reflecting a year-over-year decline of 3.3% [4] - Orthodontic and Implant Solutions reported net sales of $205 million, slightly above the estimate of $202.59 million, with a year-over-year decrease of 14.9% [4] Adjusted Operating Income - Adjusted Operating Income for Connected Technology Solutions was $10 million, significantly below the estimate of $19.2 million [4] - Wellspect Healthcare's Adjusted Operating Income was $28 million, above the average estimate of $24 million [4] - Orthodontic and Implant Solutions reported Adjusted Operating Income of $22 million, exceeding the estimate of $15.66 million [4] - Essential Dental Solutions had Adjusted Operating Income of $116 million, below the estimate of $127.61 million [4] Stock Performance - Dentsply's shares returned +1.9% over the past month, outperforming the Zacks S&P 500 composite's +1.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]